Search

everythinglearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Thermal hair straightening changes drug levels in hair, affecting test results.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

Chemotherapy causes hair loss, nausea, fatigue, and blood issues, but counseling can help manage these effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Chemical hair straightening significantly reduces detectable drug levels in hair.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Targeted cancer therapies often cause serious skin problems that need careful management.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.